FATE THERAPEUTICS INC Amortization of Debt Issuance Costs and Discounts
FATE THERAPEUTICS INC (FATE) reported Amortization of Debt Issuance Costs and Discounts of $115.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2022-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2022-02-28
- FATE THERAPEUTICS INC amortization of debt issuance costs and discounts for the quarter ending 2019-12-31 was $68.00K, a 257.89% increase year-over-year.
- FATE THERAPEUTICS INC amortization of debt issuance costs and discounts for the quarter ending 2019-09-30 was $15.00K, a 21.05% decline year-over-year.
- FATE THERAPEUTICS INC amortization of debt issuance costs and discounts for the quarter ending 2019-06-30 was $17.00K, a 10.53% decline year-over-year.
- FATE THERAPEUTICS INC amortization of debt issuance costs and discounts for the quarter ending 2019-03-31 was $15.00K, a 21.05% decline year-over-year.
- FATE THERAPEUTICS INC amortization of debt issuance costs and discounts for fiscal 2019 was $115.00K, a 51.32% increase from fiscal 2018.
- FATE THERAPEUTICS INC amortization of debt issuance costs and discounts for fiscal 2018 was $76.00K, a 6.17% decline from fiscal 2017.
- FATE THERAPEUTICS INC amortization of debt issuance costs and discounts for fiscal 2017 was $81.00K, a 41.73% decline from fiscal 2016.
- FATE THERAPEUTICS INC amortization of debt issuance costs and discounts for fiscal 2016 was $139.00K, a 21.02% decline from fiscal 2015.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2019-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $83.00K derived: sum of 2 quarters · filed 2022-02-28 | $100.00K derived: sum of 3 quarters · filed 2022-02-28 | $115.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $32.00K derived: sum of 2 quarters · filed 2020-11-05 | $47.00K 10-Q · filed 2020-11-05 | $66.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $32.00K 10-Q · filed 2020-08-05 | $51.00K derived: sum of 3 quarters · filed 2021-02-24 | $70.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $15.00K 10-Q · filed 2020-05-11 | $34.00K derived: sum of 2 quarters · filed 2021-02-24 | $53.00K derived: sum of 3 quarters · filed 2021-02-24 | $72.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $38.00K derived: sum of 2 quarters · filed 2021-02-24 | $57.00K derived: sum of 3 quarters · filed 2021-02-24 | $76.00K 10-K · filed 2021-02-24 |
| 2018-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $38.00K derived: sum of 2 quarters · filed 2019-11-05 | $57.00K 10-Q · filed 2019-11-05 | $76.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $38.00K 10-Q · filed 2019-08-06 | $57.00K derived: sum of 3 quarters · filed 2020-03-02 | $76.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $19.00K 10-Q · filed 2019-05-07 | $38.00K derived: sum of 2 quarters · filed 2020-03-02 | $57.00K derived: sum of 3 quarters · filed 2020-03-02 | $76.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $38.00K derived: sum of 2 quarters · filed 2020-03-02 | $57.00K derived: sum of 3 quarters · filed 2020-03-02 | $81.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $38.00K derived: sum of 2 quarters · filed 2018-11-01 | $62.00K 10-Q · filed 2018-11-01 | $90.00K derived: sum of 4 quarters · filed 2019-03-05 |
| 2017-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $43.00K 10-Q · filed 2018-08-06 | $71.00K derived: sum of 3 quarters · filed 2019-03-05 | $104.00K derived: sum of 4 quarters · filed 2019-03-05 |
| 2017-03-31 | $24.00K 10-Q · filed 2018-05-10 | $52.00K derived: sum of 2 quarters · filed 2019-03-05 | $85.00K derived: sum of 3 quarters · filed 2019-03-05 | $123.00K derived: sum of 4 quarters · filed 2019-03-05 |
| 2016-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | $61.00K derived: sum of 2 quarters · filed 2019-03-05 | $99.00K derived: sum of 3 quarters · filed 2019-03-05 | $139.00K 10-K · filed 2019-03-05 |
| 2016-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $71.00K derived: sum of 2 quarters · filed 2017-11-01 | $111.00K 10-Q · filed 2017-11-01 | $155.00K derived: sum of 4 quarters · filed 2018-03-05 |
| 2016-06-30 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $78.00K 10-Q · filed 2017-08-14 | $122.00K derived: sum of 3 quarters · filed 2018-03-05 | $167.00K derived: sum of 4 quarters · filed 2018-03-05 |
| 2016-03-31 | $40.00K 10-Q · filed 2017-05-15 | $84.00K derived: sum of 2 quarters · filed 2018-03-05 | $129.00K derived: sum of 3 quarters · filed 2018-03-05 | $172.00K derived: sum of 4 quarters · filed 2018-03-05 |
| 2015-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $89.00K derived: sum of 2 quarters · filed 2018-03-05 | $132.00K derived: sum of 3 quarters · filed 2018-03-05 | $176.00K 10-K · filed 2018-03-05 |
| 2015-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $88.00K derived: sum of 2 quarters · filed 2016-11-07 | $132.00K 10-Q · filed 2016-11-07 | $139.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $87.00K 10-Q · filed 2016-08-08 | $94.00K derived: sum of 3 quarters · filed 2017-03-16 | $97.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $44.00K 10-Q · filed 2016-05-09 | $51.00K derived: sum of 2 quarters · filed 2017-03-16 | $54.00K derived: sum of 3 quarters · filed 2017-03-16 | $60.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $10.00K derived: sum of 2 quarters · filed 2017-03-16 | $16.00K derived: sum of 3 quarters · filed 2017-03-16 | $24.00K 10-K · filed 2017-03-16 |
| 2014-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $9.00K derived: sum of 2 quarters · filed 2015-11-03 | $17.00K 10-Q · filed 2015-11-03 | |
| 2014-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $14.00K 10-Q · filed 2015-08-05 | ||
| 2014-03-31 | $8.00K 10-Q · filed 2015-05-07 | |||
| 2013-12-31 | $394.00K 10-K · filed 2016-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |